Lonial, S, Popat, R, Hulin, C, Jagannath, S, Oriol, A, Richardson, P G, Facon, T, Weisel, K, Larsen, J T, Minnema, M C, Abdallah, A-O, Badros, A Z, Knop, S, Stadtmauer, E A, Cheng, Y, Amatangelo, M, Chen, M, Nguyen, T V, Amin, A, Peluso, T & van de Donk, N W C J 2022, ' Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001) : a multicentre, multicohort, open-label, phase 1/2 trial ', The Lancet Haematology, vol. 9, no. 11, pp. e822-e832 . https://doi.org/10.1016/S2352-3026(22)00290-3 The Lancet Haematology, 9(11), e822-e832. Lancet Publishing Group